Covered recipient · General Payments record
CASSIE MARIE TILTON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2022–2024
$678.18
- Reported across 41 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $258.27 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $48.32 | 3 |
| Merck Sharp & Dohme Corporation | $33.52 | 2 |
| DEXCOM, INC. | $31.24 | 2 |
| Amgen Inc. | $30.43 | 2 |
| Lilly USA, LLC | $27.39 | 2 |
| Abbott Laboratories | $16.30 | 1 |
| Acerta Pharma LLC | $15.07 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $14.88 | 1 |
| Ardelyx, Inc. | $14.29 | 1 |
| Kowa Pharmaceuticals America, Inc. | $13.53 | 1 |
| Novo Nordisk AS | $13.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.30 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124838813 | CMS |
| ABBVIE INC. | $13.07 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108311831 | CMS |
| ABBVIE INC. | $18.09 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108311833 | CMS |
| ABBVIE INC. | $17.16 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108311835 | CMS |
| Amgen Inc. | $16.72 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117701466 | CMS |
| Amgen Inc. | $13.71 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117701468 | CMS |
| Ardelyx, Inc. | $14.29 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146748087 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.07 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104257407 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $14.88 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086290894 | CMS |
| Dexcom, Inc. | $16.71 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153353622 | CMS |
| Dexcom, Inc. | $14.53 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153353624 | CMS |
| Kowa Pharmaceuticals America, Inc. | $13.53 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113474991 | CMS |
| Lilly USA, LLC | $14.03 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135555724 | CMS |
| Lilly USA, LLC | $13.36 | 07/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135587667 | CMS |
| Merck Sharp & Dohme LLC | $18.23 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141631963 | CMS |
| Merck Sharp & Dohme LLC | $15.29 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141848498 | CMS |
| Novo Nordisk Inc | $13.30 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100654535 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.